Taiko Pharmaceutical Co Ltd
TSE:4574

Watchlist Manager
Taiko Pharmaceutical Co Ltd Logo
Taiko Pharmaceutical Co Ltd
TSE:4574
Watchlist
Price: 299 JPY 0.67% Market Closed
Market Cap: ¥15.1B

Taiko Pharmaceutical Co Ltd
Inventory

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Taiko Pharmaceutical Co Ltd
Inventory Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Inventory CAGR 3Y CAGR 5Y CAGR 10Y
Taiko Pharmaceutical Co Ltd
TSE:4574
Inventory
¥1.6B
CAGR 3-Years
-6%
CAGR 5-Years
-24%
CAGR 10-Years
-1%
Hoya Corp
TSE:7741
Inventory
¥133.7B
CAGR 3-Years
8%
CAGR 5-Years
11%
CAGR 10-Years
7%
H
Hogy Medical Co Ltd
TSE:3593
Inventory
¥9.4B
CAGR 3-Years
3%
CAGR 5-Years
4%
CAGR 10-Years
3%
A
Asahi Intecc Co Ltd
TSE:7747
Inventory
¥26.5B
CAGR 3-Years
-2%
CAGR 5-Years
7%
CAGR 10-Years
12%
Mani Inc
TSE:7730
Inventory
¥6.6B
CAGR 3-Years
4%
CAGR 5-Years
0%
CAGR 10-Years
2%
Nipro Corp
TSE:8086
Inventory
¥261.4B
CAGR 3-Years
8%
CAGR 5-Years
10%
CAGR 10-Years
9%
No Stocks Found

Taiko Pharmaceutical Co Ltd
Glance View

Market Cap
15.1B JPY
Industry
Health Care

Taiko Pharmaceutical Co., Ltd. engages in the manufacture and sale of general medications particularly non-prescription gastrointestinal drugs and designated quasi drugs. The company is headquartered in Osaka, Osaka-Fu and currently employs 264 full-time employees. The company went IPO on 2009-03-18. The firm is engaged in three business segments. The Pharmaceutical Product segment is engaged in the manufacturing, sales and export of gastrointestinal drugs under the name SEIROGAN, SEIROGAN TOI-A (sugar coated tablet) and PISHUT. The Infection Control segment is engaged in the planning, development and sales of infection control products, which apply proprietary technique regarding chlorine dioxide gas. The Others segment is engaged in the manufacturing and sales of bath liquid, soap and gardening pyroligneous acid.

Intrinsic Value
403.57 JPY
Undervaluation 26%
Intrinsic Value
Price ¥299

See Also

What is Taiko Pharmaceutical Co Ltd's Inventory?
Inventory
1.6B JPY

Based on the financial report for Dec 31, 2025, Taiko Pharmaceutical Co Ltd's Inventory amounts to 1.6B JPY.

What is Taiko Pharmaceutical Co Ltd's Inventory growth rate?
Inventory CAGR 10Y
-1%

Over the last year, the Inventory growth was -3%. The average annual Inventory growth rates for Taiko Pharmaceutical Co Ltd have been -6% over the past three years , -24% over the past five years , and -1% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett